BRIEF published on 06/23/2025 at 08:50, 1 year 3 months ago EDENRED Initiates New Share Buyback Agreement Edenred Share Buyback Investment Financial Strategy Stock Cancellation
REGULATED PRESS RELEASE published on 06/23/2025 at 08:45, 1 year 3 months ago Share buyback mandate Edenred extends share buyback, agreeing to repurchase shares for up to €25 million until July 31, 2025, with plans to increase to €250 million by November 2027. 9.7 million shares bought back for €350 million by June 20, 2025 Edenred Share Repurchase Share Buyback Investment Services Provider Corporate Clients
BRIEF published on 06/05/2025 at 10:03, 1 year 4 months ago Edenred's Share Capital and Voting Rights Update as of May 31, 2025 Edenred Share Capital Voting Rights Financial Disclosure May 2025
REGULATED PRESS RELEASE published on 06/05/2025 at 09:58, 1 year 4 months ago Disclosure of Share Capital and Voting Rights as of May 31, 2025 Edenred discloses share capital and voting rights per French regulations. Details of outstanding shares and voting rights provided excluding treasury shares Edenred Share Capital Voting Rights French Regulations Treasury Shares
BRIEF published on 05/07/2025 at 19:08, 1 year 5 months ago Edenred Announces Share Capital Reduction through Treasury Share Cancellation Treasury Shares Buyback Program Financial Strategy Share Capital Reduction Edenred SE
REGULATED PRESS RELEASE published on 05/07/2025 at 19:03, 1 year 5 months ago Share capital decrease by way of treasury shares cancellation Edenred SE decreases share capital by canceling 1,635,606 treasury shares, improving financial structure and enhancing shareholder value Shareholder Value Financial Structure Treasury Shares Edenred SE Share Capital Decrease
BRIEF published on 05/07/2025 at 18:20, 1 year 5 months ago Edenred’s 2025 General Meeting Approves All Resolutions Dividend Approval Edenred General Meeting Beyond22-25 Strategy Revenue And EBITDA Growth CSR Progress
REGULATED PRESS RELEASE published on 05/07/2025 at 18:15, 1 year 5 months ago Edenred’s 2025 General Meeting approves all resolutions Edenred's 2025 General Meeting approves all resolutions. Beyond22-25 strategy success, revenue growth, and financial performance highlighted. Key board appointments and committees disclosed Edenred Revenue Growth Financial Performance 2025 General Meeting Beyond22-25 Strategy
BRIEF published on 05/06/2025 at 10:36, 1 year 5 months ago EDENRED: Share Capital and Voting Rights Update Edenred Share Capital Voting Rights Financial Disclosure April 2025
REGULATED PRESS RELEASE published on 05/06/2025 at 10:31, 1 year 5 months ago Disclosure of Share Capital and Voting Rights as of April 30, 2025 Edenred discloses share capital and voting rights in accordance with French regulations. Details available on edenred.com under Investors/Shareholders section Edenred Share Capital Voting Rights Investors French Regulations
Published on 10/12/2026 at 22:01, 46 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 7 hours 47 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 9 hours 47 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 18 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 20 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/12/2026 at 20:30, 2 hours 17 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 2 hours 17 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 2 hours 42 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 3 hours 37 minutes ago Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 18:45, 4 hours 2 minutes ago Fraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth
Published on 10/12/2026 at 17:59, 4 hours 47 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 5 hours 2 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 6 hours 59 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Published on 10/12/2026 at 15:12, 7 hours 35 minutes ago Statement of transactions in own shares from October 5, 2026 to October 9, 2026
